Lapatinib
About
Therapy type: Targeted therapy
Therapy strategy: HER2 inhibition
Mappings
NCI Thesaurus: Lapatinib (ncit:C26653)
RxNorm: lapatinib (rxcui:480167, omop:1359548)
SNOMED: Lapatinib (sctid:425820005, omop:4143400)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) HC (1) | HER2-positive | Invasive Breast Carcinoma | Capecitabine, Lapatinib | |
| FDA (1) | ER positive, HER2-positive | Invasive Breast Carcinoma | Lapatinib, Letrozole | |
| FDA (1) | HER2-positive, PR positive | Invasive Breast Carcinoma | Lapatinib, Letrozole | |
| FDA (1) | ER positive, HER2-positive, PR positive | Invasive Breast Carcinoma | Lapatinib, Letrozole |